Eculizumab

/Tag:Eculizumab

LONG-TERM ECULIZUMAB TREATMENT CONTRIBUTES TO RECOVERY FROM END-STAGE RENAL DISEASE ASSOCIATED WITH ATYPICAL HEMOLYTIC UREMIC SYNDROME

Case Presentation: A 38-year-old Japanese man with past medical history of central retinal vein occlusion at the age of 36 years presented with one-week duration of dyspnea, precipitated by common cold-like symptoms. He denied having [...]

By | 2017-04-20T15:49:32+00:00 April 20th, 2017|Adult, Clinical Vignette Abstracts|Comments Off on LONG-TERM ECULIZUMAB TREATMENT CONTRIBUTES TO RECOVERY FROM END-STAGE RENAL DISEASE ASSOCIATED WITH ATYPICAL HEMOLYTIC UREMIC SYNDROME

THERE WILL BE BLOOD: THE DILEMMA OF TREATING PAROXYSMAL NOCTURNAL HEMOGLOBINURIA IN THE PRESENCE OF NEW DRUG-ELUTING STENTS

Case Presentation: A 58-year-old Caucasian woman with HIV on HAART, hyperthyroidism with radioiodine ablation, Hepatitis B and C, past IV drug use, former smoker, HTN, and HLD, initially presented with chest pain and was found [...]

By | 2019-03-11T14:44:41+00:00 March 11th, 2019|Adult, Clinical Vignettes, Hospital Medicine 2019|Comments Off on THERE WILL BE BLOOD: THE DILEMMA OF TREATING PAROXYSMAL NOCTURNAL HEMOGLOBINURIA IN THE PRESENCE OF NEW DRUG-ELUTING STENTS

Typical Hemolytic Uremic Syndrome: Supportive Treatment Only, Plasma Exchange or Monoclonal Antibody?

Case Presentation: A 20-year-old female with no significant past medical history presented to the ED with a 1 day history of fever, vomiting, abdominal pain and multiple episodes of bloody stool. On physical examination, she [...]

By | 2017-04-17T12:10:00+00:00 February 1st, 2016|Adult, Clinical Vignettes Abstracts|Comments Off on Typical Hemolytic Uremic Syndrome: Supportive Treatment Only, Plasma Exchange or Monoclonal Antibody?